BIOMAT Database Logo BIOMAT Database Logo

High anti-double-stranded DNA antibodies and progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. 2005

Stefaan J Vandecasteele, and Bart Maes, and Kathleen Claes, and Raf Sciot, and Yves Vanrenterghem
Department of Nephrology and Infectious Diseases, Sint-Jans Hospital, Brugge, Belgium.

UI MeSH Term Description Entries
D007577 JC Virus A species of POLYOMAVIRUS, originally isolated from the brain of a patient with progressive multifocal leukoencephalopathy. The patient's initials J.C. gave the virus its name. Infection is not accompanied by any apparent illness but serious demyelinating disease can appear later, probably following reactivation of latent virus. Human Polyomavirus JC,JC polyomavirus,Polyomavirus, JC,John Cunningham Virus,Polyomavirus hominis 2,Polyomavirus JC, Human,Virus, John Cunningham
D007968 Leukoencephalopathy, Progressive Multifocal An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7) Encephalitis, JC Polyomavirus,Progressive Multifocal Leukoencephalopathy,JC Polyomavirus Encephalopathy,Encephalopathies, JC Polyomavirus,Encephalopathy, JC Polyomavirus,JC Polyomavirus Encephalitis,Leukoencephalopathies, Progressive Multifocal,Multifocal Leukoencephalopathies, Progressive,Multifocal Leukoencephalopathy, Progressive,Progressive Multifocal Leukoencephalopathies
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003596 Cytosine A pyrimidine base that is a fundamental unit of nucleic acids.
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077404 Cidofovir An acyclic nucleoside phosphonate that acts as a competitive inhibitor of viral DNA polymerases. It is used in the treatment of RETINITIS caused by CYTOMEGALOVIRUS INFECTIONS and may also be useful for treating HERPESVIRUS INFECTIONS. 1-((3-Hydroxy-2-phosphonylmethoxy)propyl)cytosine,1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine,Cidofovir Anhydrous,Cidofovir Sodium,Cidofovir, (+-)-isomer,Cidofovir, (R)-isomer,Cidofovir, Sodium Salt,GS 504,GS-504,HPMPC,Vistide,GS504
D000888 Antibodies, Anti-Idiotypic Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies. Anti-Antibodies,Anti-Idiotype Antibodies,Antibodies, Internal Image,Antigamma Globulin Antibodies,Antiglobulins,Anti Antibodies,Anti-gamma Globulin Antibodies,Anti Idiotype Antibodies,Anti gamma Globulin Antibodies,Anti-Idiotypic Antibodies,Antibodies, Anti,Antibodies, Anti Idiotypic,Antibodies, Anti-Idiotype,Antibodies, Anti-gamma Globulin,Antibodies, Antigamma Globulin,Globulin Antibodies, Anti-gamma,Globulin Antibodies, Antigamma,Image Antibodies, Internal,Internal Image Antibodies

Related Publications

Stefaan J Vandecasteele, and Bart Maes, and Kathleen Claes, and Raf Sciot, and Yves Vanrenterghem
Progressive Multifocal Leukoencephalopathy in a Patient with Systemic Lupus Erythematosus.
October 2022, Rheumatology and immunology research,
Stefaan J Vandecasteele, and Bart Maes, and Kathleen Claes, and Raf Sciot, and Yves Vanrenterghem
Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus.
July 1999, The Journal of rheumatology,
Stefaan J Vandecasteele, and Bart Maes, and Kathleen Claes, and Raf Sciot, and Yves Vanrenterghem
[Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus].
May 2019, Brain and nerve = Shinkei kenkyu no shinpo,
Stefaan J Vandecasteele, and Bart Maes, and Kathleen Claes, and Raf Sciot, and Yves Vanrenterghem
Progressive multifocal leukoencephalopathy in systemic lupus erythematosus.
March 2007, Arthritis and rheumatism,
Stefaan J Vandecasteele, and Bart Maes, and Kathleen Claes, and Raf Sciot, and Yves Vanrenterghem
Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus.
January 2012, Internal medicine (Tokyo, Japan),
Stefaan J Vandecasteele, and Bart Maes, and Kathleen Claes, and Raf Sciot, and Yves Vanrenterghem
Progressive multifocal leukoencephalopathy complicating systemic lupus erythematosus.
March 1986, Arthritis and rheumatism,
Stefaan J Vandecasteele, and Bart Maes, and Kathleen Claes, and Raf Sciot, and Yves Vanrenterghem
Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus and autoimmune hepatitis.
June 2022, International journal of rheumatic diseases,
Stefaan J Vandecasteele, and Bart Maes, and Kathleen Claes, and Raf Sciot, and Yves Vanrenterghem
Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus.
March 2006, Arthritis and rheumatism,
Stefaan J Vandecasteele, and Bart Maes, and Kathleen Claes, and Raf Sciot, and Yves Vanrenterghem
Progressive multifocal leukoencephalopathy associated with belimumab in a patient with systemic lupus erythematosus.
March 2015, The Journal of rheumatology,
Stefaan J Vandecasteele, and Bart Maes, and Kathleen Claes, and Raf Sciot, and Yves Vanrenterghem
Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus: Clues to early diagnosis.
September 2019, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
Copied contents to your clipboard!